Losartan/Hydrochlorothiazide Bluefish 100 mg / 25 mg Noorwegen - Noors - Statens legemiddelverk

losartan/hydrochlorothiazide bluefish 100 mg / 25 mg

bluefish pharmaceuticals ab - losartankalium / hydroklortiazid - tablett, filmdrasjert - 100 mg / 25 mg

Losartan/Hydrochlorothiazide Bluefish 50 mg / 12.5 mg Noorwegen - Noors - Statens legemiddelverk

losartan/hydrochlorothiazide bluefish 50 mg / 12.5 mg

bluefish pharmaceuticals ab - losartankalium / hydroklortiazid - tablett, filmdrasjert - 50 mg / 12.5 mg

Zanosar 1 g Noorwegen - Noors - Statens legemiddelverk

zanosar 1 g

esteve pharmaceuticals s.a.s. - streptozocin - pulver til konsentrat til infusjonsvæske, oppløsning - 1 g

Qinlock Europese Unie - Noors - EMA (European Medicines Agency)

qinlock

deciphera pharmaceuticals (netherlands) b.v. - ripretinib - gastrointestinal stromal tumors - antineoplastiske midler - qinlock is indicated for the treatment of adult patients with advanced gastrointestinal stromal tumour (gist) who have received prior treatment with three or more kinase inhibitors, including imatinib.

Xagrid Europese Unie - Noors - EMA (European Medicines Agency)

xagrid

takeda pharmaceuticals international ag ireland branch - anagrelide - trombocytemi, essensielt - antineoplastiske midler - xagrid angis for reduksjon av opphøyet platederivert teller i risikosonen essensielle-thrombocythaemia (et) pasienter som er intolerante for deres nåværende terapi eller med forhøyet platederivert teller ikke reduseres til et akseptabelt nivå av deres nåværende behandling. en risiko patientan på risiko og er definert av ett eller flere av følgende funksjoner:>60 år eller;en blodplater >1000 x 109/l eller;en historie av thrombohaemorrhagic arrangementer.

Bactrim 40 mg/ ml / 8 mg/ ml Noorwegen - Noors - Statens legemiddelverk

bactrim 40 mg/ ml / 8 mg/ ml

eumedica pharmaceuticals gmbh - sulfametoksazol / trimetoprim - mikstur, suspensjon - 40 mg/ ml / 8 mg/ ml

Mirtazapin Bluefish 45 mg Noorwegen - Noors - Statens legemiddelverk

mirtazapin bluefish 45 mg

bluefish pharmaceuticals ab - mirtazapin - smeltetablett - 45 mg

Mirtazapin Bluefish 15 mg Noorwegen - Noors - Statens legemiddelverk

mirtazapin bluefish 15 mg

bluefish pharmaceuticals ab - mirtazapin - smeltetablett - 15 mg

Mirtazapin Bluefish 30 mg Noorwegen - Noors - Statens legemiddelverk

mirtazapin bluefish 30 mg

bluefish pharmaceuticals ab - mirtazapin - smeltetablett - 30 mg

Pedmarqsi Europese Unie - Noors - EMA (European Medicines Agency)

pedmarqsi

fennec pharmaceuticals (eu) limited - sodium thiosulfate - ear diseases; ototoxicity - alle andre terapeutiske produkter - pedmarqsi is indicated for the prevention of ototoxicity induced by cisplatin chemotherapy in patients 1 month to < 18 years of age with localised, non-metastatic, solid tumours.